An observational study in Spontaneous Bacterial Peritonitis, sponsored by Assiut University. Not yet recruiting at 2 sites in Egypt. Open to participants aged Up to 80 Years. Per ClinicalTrials.gov, last updated 2025-01-16.
Sponsored by Assiut University · Observational
Spontaneous bacterial peritonitis (SBP) is a common complication in cirrhotic patients. The prevalence of SBP in hospitalized patients and the mortality rate were reported to be 10%-30% and 30%-50%, respectively.
SBP has been considered a life-threatening infection that requires a prompt diagnosis and treatment.
167 studies on the registry are indexed under Peritonitis; 23 are open to participants now.
This study's planned enrollment of 101 is below the median of 137 across 55 observational studies indexed under Peritonitis.
Browse Peritonitis studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Any cirrhotic patient above the age of 18 years old of both sexes, having a first episode of SBP will be included in our study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Any cirrhotic patient above the age of 18 years old of both sexes, having a first episode of SBP will be included in our study.
Exclusion Criteria:
Any patient with one or more of the following criteria will be excluded:
Frequency and Predictors of Recurrent Spontaneous Bacterial Peritonitis in Cirrhotic Patients in Al Rajhi University Hospital.
Determine the frequency of recurrent SBP after its management within one year
Time frame: One year
Predictors of recurrent SBP
Determining risk factors of recurrent SBP
Time frame: One year
This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.